HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jingfeng Xu Selected Research

sanggenone C

8/2020Sanggenon C Ameliorates Cerebral Ischemia-Reperfusion Injury by Inhibiting Inflammation and Oxidative Stress through Regulating RhoA-ROCK Signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jingfeng Xu Research Topics

Disease

2Inflammation (Inflammations)
08/2020 - 08/2010
1Infections
01/2022
1Adenocarcinoma of Lung
09/2020
1Neoplasms (Cancer)
09/2020
1Sinus Histiocytosis (Rosai-Dorfman Disease)
09/2020
1Headache Disorders (Headache Syndromes)
09/2020
1Brain Ischemia (Cerebral Ischemia)
08/2020
1Hypoxia (Hypoxemia)
08/2020
1Reperfusion Injury
08/2020
1Brain Injuries (Brain Injury)
08/2020
1Myocarditis (Carditis)
08/2010

Drug/Important Bio-Agent (IBA)

1Complementary DNA (cDNA)IBA
01/2022
1ErbB Receptors (EGF Receptor)IBA
09/2020
1Anaplastic Lymphoma KinaseIBA
09/2020
1C-Reactive ProteinIBA
09/2020
1Immunoglobulin G (IgG)IBA
09/2020
1FlavonoidsIBA
08/2020
1Neuroprotective AgentsIBA
08/2020
1sanggenone CIBA
08/2020
1Proteins (Proteins, Gene)FDA Link
08/2020
1AntioxidantsIBA
08/2020
1ChloridesIBA
08/2020
1NF-kappa B (NF-kB)IBA
08/2010
1cinnamaldehyde (cinnamic aldehyde)FDA Link
08/2010
1cinnamic acidIBA
08/2010
1Antiviral Agents (Antivirals)IBA
08/2010
1Toll-Like Receptors (Toll-Like Receptor)IBA
08/2010